DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the second quarter ended June 30, 2021 on Monday, August 16, 2021, and host a conference call and webcast at 8:30 am Eastern Time.
Glooko Inc., the leading provider of remote patient monitoring and data management platforms in diabetes and related chronic conditions, announced the appointment of Prakash Menon as the Company’s Chief Technology Officer.
LifeScan, a world leader in blood glucose monitoring serving more than 20 million people with diabetes, and Fitbit, today announced a collaboration to offer people with diabetes a more complete view of how lifestyle factors like daily activity, nutrition and sleep can impact blood glucose levels, while also providing tools that can help lead to healthy lifestyle changes. New collaboration provides more holistic support through connectivity between the OneTouch Reveal® diabetes management and Fitbit apps.
#product & service
#bgm
#mobile app
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented the Omnipod DASH® Insulin Management System (Omnipod DASH) to healthcare providers attending the virtual Australasian Diabetes Congress. Insulet expects to begin taking customer orders for Omnipod DASH by the end of August.
#insulin pump
This study reports a clinical evaluation of AiDEX CGM system featuring a 14-day sensor, real-time glucose monitoring and factory-calibration. A multicenter, prospective, masked clinical study was conducted at with a total of 120 participants. Each participant wore 4 studied sensors and had one in-clinic visit for venous blood reference tests. 40 out of the 120 participants wore additional Abbott Libre sensors and performed at least 7 capillary BG tests daily for additional reference and comparison.
#cgm
BD, a leading global medical technology company, today announced that Christopher DelOrefice has been named executive vice president and chief financial officer (CFO), effective Sept. 6, 2021. DelOrefice succeeds Christopher Reidy, 64, who announced his intent to retire from BD last week.
Brighter AB (publ) announced today that Christopher Robinson will assume the role of acting Chief Financial Officer (CFO) at Brighter affecting August 16th, 2021. Christopher is an entrepreneurial finance professional with 20 years of experience working in growing international environments.
Brighter AB [publ], today has published first quarter interim report for April – June 2021. The full report is available on the company website https://brighter.se.
New Study Presented at American Association of Diabetes Care and Education Specialists Annual Conference Highlights the Clinical Strength of Dario’s AI-Driven Journey Engine. Research demonstrates a 19% improvement in blood glucose readings.
#dtx
To compare healthcare utilization, costs, and incidence of diabetes-specific adverse events (ie, hyperglycemia, diabetic ketoacidosis, and hypoglycemia) in type 1 diabetes adult patients using real-time continuous glucose monitoring (rtCGM) versus traditional blood glucose monitoring (BG).
#cgm